Baird Maintains Outperform on DexCom, Raises Price Target to $153
Portfolio Pulse from Benzinga Newsdesk
Baird analyst Jeff Johnson maintains an Outperform rating on DexCom (NASDAQ:DXCM) and raises the price target from $145 to $153.
July 28, 2023 | 11:47 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Baird analyst Jeff Johnson maintains an Outperform rating on DexCom and raises the price target from $145 to $153. This could potentially lead to an increase in the stock price.
The raised price target by Baird indicates a positive outlook for DexCom. This could potentially lead to an increase in the stock price as it suggests that the stock is undervalued at its current price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100